Mirati Therapeutics, Inc. (MRTX) Social Stream
MIRATI THERAPEUTICS INC (MRTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering MIRATI THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 10 | $235 | $171 | $198.857 | $58.9 | 237.62% |
| 2021-11-16 | 10 | $235 | $171 | $197 | $58.9 | 234.47% |
| 2021-11-19 | 11 | $235 | $171 | $195.75 | $58.9 | 232.34% |
| 2022-01-31 | 10 | $235 | $171 | $195.75 | $58.9 | 232.34% |
| 2022-02-01 | 9 | $235 | $141 | $188.875 | $58.9 | 220.67% |
| 2022-02-16 | 10 | $219 | $141 | $173.125 | $58.9 | 193.93% |
| 2022-02-17 | 10 | $219 | $121 | $159.75 | $58.9 | 171.22% |
| 2022-03-01 | 10 | $219 | $118 | $154.5 | $58.9 | 162.31% |
| 2022-04-28 | 10 | $203 | $117 | $147.125 | $58.9 | 149.79% |
| 2022-05-04 | 10 | $203 | $99 | $138.75 | $58.9 | 135.57% |
| 2022-05-06 | 10 | $208 | $99 | $138.444 | $58.9 | 135.05% |
| 2022-05-12 | 10 | $208 | $99 | $140.444 | $58.9 | 138.44% |
| 2022-05-20 | 12 | $208 | $99 | $137.9 | $58.9 | 134.13% |
| 2022-05-26 | 12 | $216 | $82 | $143.454 | $58.9 | 143.56% |
| 2022-06-01 | 11 | $216 | $82 | $136.09 | $58.9 | 131.05% |
| 2022-06-07 | 11 | $208 | $72 | $128.083 | $58.9 | 117.46% |
| 2022-07-27 | 12 | $188 | $72 | $121.916 | $58.9 | 106.99% |
| 2022-08-04 | 12 | $188 | $79 | $120.916 | $58.9 | 105.29% |
| 2022-08-08 | 13 | $188 | $85 | $124.636 | $58.9 | 111.61% |
| 2022-08-18 | 13 | $188 | $85 | $123.333 | $58.9 | 109.39% |
| 2022-09-17 | 14 | $188 | $85 | $122.538 | $58.9 | 108.04% |
| 2022-10-12 | 14 | $188 | $85 | $121.384 | $58.9 | 106.08% |
| 2022-10-14 | 14 | $188 | $85 | $121.307 | $58.9 | 105.95% |
| 2022-11-09 | 15 | $188 | $72 | $117.785 | $58.9 | 99.97% |
| 2022-11-16 | 15 | $188 | $72 | $116.357 | $58.9 | 97.55% |
| 2022-11-30 | 14 | $188 | $72 | $111.692 | $58.9 | 89.63% |
| 2022-12-09 | 15 | $188 | $52 | $88.357 | $58.9 | 50.01% |
| 2022-12-12 | 15 | $188 | $52 | $86 | $58.9 | 46.01% |
| 2022-12-13 | 16 | $188 | $52 | $85.285 | $58.9 | 44.8% |
| 2022-12-14 | 16 | $188 | $52 | $83.714 | $58.9 | 42.13% |
| 2023-01-23 | 16 | $188 | $53 | $84.4 | $58.9 | 43.29% |
| 2023-01-26 | 16 | $188 | $53 | $81.4 | $58.9 | 38.2% |
| 2023-02-08 | 16 | $188 | $50 | $80.733 | $58.9 | 37.07% |
| 2023-03-01 | 15 | $188 | $50 | $80.733 | $58.9 | 37.07% |
| 2023-04-25 | 16 | $188 | $50 | $79.6 | $58.9 | 35.14% |
| 2023-05-10 | 16 | $188 | $50 | $76.333 | $58.9 | 29.6% |
| 2023-05-11 | 15 | $188 | $50 | $73.357 | $58.9 | 24.54% |
| 2023-05-29 | 14 | $188 | $40 | $70.153 | $58.9 | 19.11% |
| 2023-06-06 | 14 | $82 | $40 | $60.416 | $58.9 | 2.57% |
| 2023-07-13 | 14 | $82 | $40 | $60.333 | $58.9 | 2.43% |
| 2023-07-14 | 14 | $82 | $40 | $59.666 | $58.9 | 1.3% |
| 2023-07-24 | 15 | $82 | $40 | $59.153 | $58.9 | 0.43% |
| 2023-07-26 | 15 | $82 | $40 | $58.846 | $58.9 | -0.09% |
| 2023-08-09 | 16 | $82 | $40 | $58.846 | $58.9 | -0.09% |
| 2023-09-21 | 17 | $83 | $31 | $54.5 | $58.9 | -7.47% |
| 2023-09-28 | 17 | $83 | $31 | $54.285 | $58.9 | -7.84% |
| 2023-10-05 | 17 | $83 | $31 | $55.714 | $58.9 | -5.41% |
| 2023-10-09 | 17 | $83 | $37 | $61.133 | $58.9 | 3.79% |
| 2023-10-10 | 17 | $83 | $37 | $62 | $58.9 | 5.26% |
| 2023-10-25 | 16 | $83 | $37 | $62 | $58.9 | 5.26% |
| 2023-11-06 | 16 | $83 | $37 | $62 | $58.9 | 5.26% |
| 2023-11-07 | 16 | $82 | $37 | $59.066 | $58.9 | 0.28% |
| 2023-12-19 | 16 | $91 | $45 | $63.4 | $58.9 | 7.64% |
The Trend in the Analyst Price Target
MRTX's average price target has moved down $81.6 over the prior 19 months.
MRTX reports an average of 53.77% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-26 | 16 | 188 | 53 | 81.400 | 51.06 | 59.42% |
| 2023-04-17 | 16 | 188 | 50 | 79.600 | 42.24 | 88.45% |
| 2023-05-29 | 15 | 188 | 40 | 70.153 | 38.46 | 82.41% |
| 2023-07-14 | 14 | 82 | 40 | 59.583 | 35.43 | 68.17% |
| 2023-08-09 | 16 | 82 | 40 | 58.846 | 37.00 | 59.04% |
MRTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.63 | 3 | 0 | 13 | 0 | 0 | 16 |
The Trend in the Broker Recommendations
MRTX's average broker recommendation rating worsened by 1 over the prior 46 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how MIRATI THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -6079.95% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MIRATI THERAPEUTICS INC's average analyst price target is higher than 6347.87% of them.
- In the context of Pharmaceutical Products stocks, MIRATI THERAPEUTICS INC's number of analysts covering the stock is greater than 6264.14% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, MIRATI THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 5358.38% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MIRATI THERAPEUTICS INC are LEGN, CVAC, and QGEN.
View All Top Stocks by Price Target
Is MRTX a Buy, Hold or Sell? See the POWR Ratings now!